← 產業報告目錄
Antithyroid Drug Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 118報告編號 APO-f10badc091
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Antithyroid Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antithyroid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antithyroid Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Antithyroid Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antithyroid Drug include Avet Pharmaceuticals Inc., Par Pharmaceutical, Zhaohui Pharmaceutical, Hemony Pharmaceutical, Pfizer Inc, Merck KGaA, Teva Pharmaceuticals and YanJing Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antithyroid Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antithyroid Drug Market by Company
Avet Pharmaceuticals Inc.
Par Pharmaceutical
Zhaohui Pharmaceutical
Hemony Pharmaceutical
Pfizer Inc
Merck KGaA
Teva Pharmaceuticals
YanJing Pharm
Antithyroid Drug Segment by Type
Methimazole
Propylthiouracil
Other
Antithyroid Drug Segment by Application
Hospital
Pharmacy
Other
Antithyroid Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithyroid Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antithyroid Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithyroid Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antithyroid Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antithyroid Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antithyroid Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Antithyroid Drug Market Size (2021-2032)
2.2.2 Global Antithyroid Drug Sales (2021-2032)
2.2.3 Global Antithyroid Drug Market Average Price (2021-2032)
2.3 Antithyroid Drug by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Methimazole
2.3.3 Propylthiouracil
2.3.4 Other
2.4 Antithyroid Drug by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Hospital
2.4.3 Pharmacy
2.4.4 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Antithyroid Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Antithyroid Drug Sales (K Units) of Manufacturers (2021-2026)
3.3 Global Antithyroid Drug Revenue of Manufacturers (2021-2026)
3.4 Global Antithyroid Drug Average Price by Manufacturers (2021-2026)
3.5 Global Antithyroid Drug Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Antithyroid Drug, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Antithyroid Drug, Product Type & Application
3.8 Global Manufacturers of Antithyroid Drug, Established Date
3.9 Global Antithyroid Drug Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Avet Pharmaceuticals Inc.
4.1.1 Avet Pharmaceuticals Inc. Company Information
4.1.2 Avet Pharmaceuticals Inc. Business Overview
4.1.3 Avet Pharmaceuticals Inc. Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Avet Pharmaceuticals Inc. Antithyroid Drug Product Portfolio
4.1.5 Avet Pharmaceuticals Inc. Recent Developments
4.2 Par Pharmaceutical
4.2.1 Par Pharmaceutical Company Information
4.2.2 Par Pharmaceutical Business Overview
4.2.3 Par Pharmaceutical Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Par Pharmaceutical Antithyroid Drug Product Portfolio
4.2.5 Par Pharmaceutical Recent Developments
4.3 Zhaohui Pharmaceutical
4.3.1 Zhaohui Pharmaceutical Company Information
4.3.2 Zhaohui Pharmaceutical Business Overview
4.3.3 Zhaohui Pharmaceutical Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Zhaohui Pharmaceutical Antithyroid Drug Product Portfolio
4.3.5 Zhaohui Pharmaceutical Recent Developments
4.4 Hemony Pharmaceutical
4.4.1 Hemony Pharmaceutical Company Information
4.4.2 Hemony Pharmaceutical Business Overview
4.4.3 Hemony Pharmaceutical Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Hemony Pharmaceutical Antithyroid Drug Product Portfolio
4.4.5 Hemony Pharmaceutical Recent Developments
4.5 Pfizer Inc
4.5.1 Pfizer Inc Company Information
4.5.2 Pfizer Inc Business Overview
4.5.3 Pfizer Inc Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Pfizer Inc Antithyroid Drug Product Portfolio
4.5.5 Pfizer Inc Recent Developments
4.6 Merck KGaA
4.6.1 Merck KGaA Company Information
4.6.2 Merck KGaA Business Overview
4.6.3 Merck KGaA Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Merck KGaA Antithyroid Drug Product Portfolio
4.6.5 Merck KGaA Recent Developments
4.7 Teva Pharmaceuticals
4.7.1 Teva Pharmaceuticals Company Information
4.7.2 Teva Pharmaceuticals Business Overview
4.7.3 Teva Pharmaceuticals Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Teva Pharmaceuticals Antithyroid Drug Product Portfolio
4.7.5 Teva Pharmaceuticals Recent Developments
4.8 YanJing Pharm
4.8.1 YanJing Pharm Company Information
4.8.2 YanJing Pharm Business Overview
4.8.3 YanJing Pharm Antithyroid Drug Sales, Revenue and Gross Margin (2021-2026)
4.8.4 YanJing Pharm Antithyroid Drug Product Portfolio
4.8.5 YanJing Pharm Recent Developments
5 Global Antithyroid Drug Market Scenario by Region
5.1 Global Antithyroid Drug Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Antithyroid Drug Sales by Region: 2021-2032
5.2.1 Global Antithyroid Drug Sales by Region: 2021-2026
5.2.2 Global Antithyroid Drug Sales by Region: 2027-2032
5.3 Global Antithyroid Drug Revenue by Region: 2021-2032
5.3.1 Global Antithyroid Drug Revenue by Region: 2021-2026
5.3.2 Global Antithyroid Drug Revenue by Region: 2027-2032
5.4 North America Antithyroid Drug Market Facts & Figures by Country
5.4.1 North America Antithyroid Drug Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Antithyroid Drug Sales by Country (2021-2032)
5.4.3 North America Antithyroid Drug Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Antithyroid Drug Market Facts & Figures by Country
5.5.1 Europe Antithyroid Drug Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Antithyroid Drug Sales by Country (2021-2032)
5.5.3 Europe Antithyroid Drug Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Antithyroid Drug Market Facts & Figures by Country
5.6.1 Asia Pacific Antithyroid Drug Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Antithyroid Drug Sales by Country (2021-2032)
5.6.3 Asia Pacific Antithyroid Drug Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Antithyroid Drug Market Facts & Figures by Country
5.7.1 South America Antithyroid Drug Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Antithyroid Drug Sales by Country (2021-2032)
5.7.3 South America Antithyroid Drug Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Antithyroid Drug Market Facts & Figures by Country
5.8.1 Middle East and Africa Antithyroid Drug Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Antithyroid Drug Sales by Country (2021-2032)
5.8.3 Middle East and Africa Antithyroid Drug Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Antithyroid Drug Sales by Type (2021-2032)
6.1.1 Global Antithyroid Drug Sales by Type (2021-2032) & (K Units)
6.1.2 Global Antithyroid Drug Sales Market Share by Type (2021-2032)
6.2 Global Antithyroid Drug Revenue by Type (2021-2032)
6.2.1 Global Antithyroid Drug Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Antithyroid Drug Revenue Market Share by Type (2021-2032)
6.3 Global Antithyroid Drug Price by Type (2021-2032)
7 Segment by Application
7.1 Global Antithyroid Drug Sales by Application (2021-2032)
7.1.1 Global Antithyroid Drug Sales by Application (2021-2032) & (K Units)
7.1.2 Global Antithyroid Drug Sales Market Share by Application (2021-2032)
7.2 Global Antithyroid Drug Revenue by Application (2021-2032)
7.2.1 Global Antithyroid Drug Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Antithyroid Drug Revenue Market Share by Application (2021-2032)
7.3 Global Antithyroid Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Antithyroid Drug Value Chain Analysis
8.1.1 Antithyroid Drug Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Antithyroid Drug Production Mode & Process
8.2 Antithyroid Drug Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Antithyroid Drug Distributors
8.2.3 Antithyroid Drug Customers
9 Global Antithyroid Drug Analyzing Market Dynamics
9.1 Antithyroid Drug Industry Trends
9.2 Antithyroid Drug Industry Drivers
9.3 Antithyroid Drug Industry Opportunities and Challenges
9.4 Antithyroid Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Antithyroid Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Antithyroid Drug Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Antithyroid Drug Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Antithyroid Drug Revenue of Manufacturers (2021-2026)
Table 9. Global Antithyroid Drug Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Antithyroid Drug Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Antithyroid Drug Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Antithyroid Drug, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Antithyroid Drug, Product Type & Application
Table 14. Global Antithyroid Drug Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Antithyroid Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Avet Pharmaceuticals Inc. Company Information
Table 19. Avet Pharmaceuticals Inc. Business Overview
Table 20. Avet Pharmaceuticals Inc. Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Avet Pharmaceuticals Inc. Antithyroid Drug Product Portfolio
Table 22. Avet Pharmaceuticals Inc. Recent Developments
Table 23. Par Pharmaceutical Company Information
Table 24. Par Pharmaceutical Business Overview
Table 25. Par Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Par Pharmaceutical Antithyroid Drug Product Portfolio
Table 27. Par Pharmaceutical Recent Developments
Table 28. Zhaohui Pharmaceutical Company Information
Table 29. Zhaohui Pharmaceutical Business Overview
Table 30. Zhaohui Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Zhaohui Pharmaceutical Antithyroid Drug Product Portfolio
Table 32. Zhaohui Pharmaceutical Recent Developments
Table 33. Hemony Pharmaceutical Company Information
Table 34. Hemony Pharmaceutical Business Overview
Table 35. Hemony Pharmaceutical Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Hemony Pharmaceutical Antithyroid Drug Product Portfolio
Table 37. Hemony Pharmaceutical Recent Developments
Table 38. Pfizer Inc Company Information
Table 39. Pfizer Inc Business Overview
Table 40. Pfizer Inc Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Pfizer Inc Antithyroid Drug Product Portfolio
Table 42. Pfizer Inc Recent Developments
Table 43. Merck KGaA Company Information
Table 44. Merck KGaA Business Overview
Table 45. Merck KGaA Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Merck KGaA Antithyroid Drug Product Portfolio
Table 47. Merck KGaA Recent Developments
Table 48. Teva Pharmaceuticals Company Information
Table 49. Teva Pharmaceuticals Business Overview
Table 50. Teva Pharmaceuticals Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Teva Pharmaceuticals Antithyroid Drug Product Portfolio
Table 52. Teva Pharmaceuticals Recent Developments
Table 53. YanJing Pharm Company Information
Table 54. YanJing Pharm Business Overview
Table 55. YanJing Pharm Antithyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. YanJing Pharm Antithyroid Drug Product Portfolio
Table 57. YanJing Pharm Recent Developments
Table 58. Global Antithyroid Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 59. Global Antithyroid Drug Sales by Region (2021-2026) & (K Units)
Table 60. Global Antithyroid Drug Sales Market Share by Region (2021-2026)
Table 61. Global Antithyroid Drug Sales by Region (2027-2032) & (K Units)
Table 62. Global Antithyroid Drug Sales Market Share by Region (2027-2032)
Table 63. Global Antithyroid Drug Revenue by Region (2021-2026) & (US$ Million)
Table 64. Global Antithyroid Drug Revenue Market Share by Region (2021-2026)
Table 65. Global Antithyroid Drug Revenue by Region (2027-2032) & (US$ Million)
Table 66. Global Antithyroid Drug Revenue Market Share by Region (2027-2032)
Table 67. North America Antithyroid Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 68. North America Antithyroid Drug Sales by Country (2021-2026) & (K Units)
Table 69. North America Antithyroid Drug Sales by Country (2027-2032) & (K Units)
Table 70. North America Antithyroid Drug Revenue by Country (2021-2026) & (US$ Million)
Table 71. North America Antithyroid Drug Revenue by Country (2027-2032) & (US$ Million)
Table 72. Europe Antithyroid Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 73. Europe Antithyroid Drug Sales by Country (2021-2026) & (K Units)
Table 74. Europe Antithyroid Drug Sales by Country (2027-2032) & (K Units)
Table 75. Europe Antithyroid Drug Revenue by Country (2021-2026) & (US$ Million)
Table 76. Europe Antithyroid Drug Revenue by Country (2027-2032) & (US$ Million)
Table 77. Asia Pacific Antithyroid Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 78. Asia Pacific Antithyroid Drug Sales by Country (2021-2026) & (K Units)
Table 79. Asia Pacific Antithyroid Drug Sales by Country (2027-2032) & (K Units)
Table 80. Asia Pacific Antithyroid Drug Revenue by Country (2021-2026) & (US$ Million)
Table 81. Asia Pacific Antithyroid Drug Revenue by Country (2027-2032) & (US$ Million)
Table 82. South America Antithyroid Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 83. South America Antithyroid Drug Sales by Country (2021-2026) & (K Units)
Table 84. South America Antithyroid Drug Sales by Country (2027-2032) & (K Units)
Table 85. South America Antithyroid Drug Revenue by Country (2021-2026) & (US$ Million)
Table 86. South America Antithyroid Drug Revenue by Country (2027-2032) & (US$ Million)
Table 87. Middle East and Africa Antithyroid Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 88. Middle East and Africa Antithyroid Drug Sales by Country (2021-2026) & (K Units)
Table 89. Middle East and Africa Antithyroid Drug Sales by Country (2027-2032) & (K Units)
Table 90. Middle East and Africa Antithyroid Drug Revenue by Country (2021-2026) & (US$ Million)
Table 91. Middle East and Africa Antithyroid Drug Revenue by Country (2027-2032) & (US$ Million)
Table 92. Global Antithyroid Drug Sales by Type (2021-2026) & (K Units)
Table 93. Global Antithyroid Drug Sales by Type (2027-2032) & (K Units)
Table 94. Global Antithyroid Drug Sales Market Share by Type (2021-2026)
Table 95. Global Antithyroid Drug Sales Market Share by Type (2027-2032)
Table 96. Global Antithyroid Drug Revenue by Type (2021-2026) & (US$ Million)
Table 97. Global Antithyroid Drug Revenue by Type (2027-2032) & (US$ Million)
Table 98. Global Antithyroid Drug Revenue Market Share by Type (2021-2026)
Table 99. Global Antithyroid Drug Revenue Market Share by Type (2027-2032)
Table 100. Global Antithyroid Drug Price by Type (2021-2026) & (US$/Unit)
Table 101. Global Antithyroid Drug Price by Type (2027-2032) & (US$/Unit)
Table 102. Global Antithyroid Drug Sales by Application (2021-2026) & (K Units)
Table 103. Global Antithyroid Drug Sales by Application (2027-2032) & (K Units)
Table 104. Global Antithyroid Drug Sales Market Share by Application (2021-2026)
Table 105. Global Antithyroid Drug Sales Market Share by Application (2027-2032)
Table 106. Global Antithyroid Drug Revenue by Application (2021-2026) & (US$ Million)
Table 107. Global Antithyroid Drug Revenue by Application (2027-2032) & (US$ Million)
Table 108. Global Antithyroid Drug Revenue Market Share by Application (2021-2026)
Table 109. Global Antithyroid Drug Revenue Market Share by Application (2027-2032)
Table 110. Global Antithyroid Drug Price by Application (2021-2026) & (US$/Unit)
Table 111. Global Antithyroid Drug Price by Application (2027-2032) & (US$/Unit)
Table 112. Key Raw Materials
Table 113. Raw Materials Key Suppliers
Table 114. Antithyroid Drug Distributors List
Table 115. Antithyroid Drug Customers List
Table 116. Antithyroid Drug Industry Trends
Table 117. Antithyroid Drug Industry Drivers
Table 118. Antithyroid Drug Industry Restraints
Table 119. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Antithyroid Drug Product Image
Figure 5. Global Antithyroid Drug Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Antithyroid Drug Market Size (2021-2032) & (US$ Million)
Figure 7. Global Antithyroid Drug Sales (2021-2032) & (K Units)
Figure 8. Global Antithyroid Drug Average Price (US$/Unit) & (2021-2032)
Figure 9. Methimazole Product Image
Figure 10. Propylthiouracil Product Image
Figure 11. Other Product Image
Figure 12. Hospital Product Image
Figure 13. Pharmacy Product Image
Figure 14. Other Product Image
Figure 15. Global Antithyroid Drug Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Antithyroid Drug, Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Antithyroid Drug Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Antithyroid Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Antithyroid Drug Sales by Region in 2025
Figure 21. Global Antithyroid Drug Revenue by Region in 2025
Figure 22. North America Antithyroid Drug Market Size by Country in 2025
Figure 23. North America Antithyroid Drug Sales Market Share by Country (2021-2032)
Figure 24. North America Antithyroid Drug Revenue Market Share by Country (2021-2032)
Figure 25. United States Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Antithyroid Drug Market Size by Country in 2025
Figure 28. Europe Antithyroid Drug Sales Market Share by Country (2021-2032)
Figure 29. Europe Antithyroid Drug Revenue Market Share by Country (2021-2032)
Figure 30. Germany Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Netherlands Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Asia Pacific Antithyroid Drug Market Size by Country in 2025
Figure 36. Asia Pacific Antithyroid Drug Sales Market Share by Country (2021-2032)
Figure 37. Asia Pacific Antithyroid Drug Revenue Market Share by Country (2021-2032)
Figure 38. China Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Japan Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. South Korea Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. India Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Australia Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. China Taiwan Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Southeast Asia Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South America Antithyroid Drug Market Size by Country in 2025
Figure 47. South America Antithyroid Drug Sales Market Share by Country (2021-2032)
Figure 48. South America Antithyroid Drug Revenue Market Share by Country (2021-2032)
Figure 49. Mexico Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Brazil Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Argentina Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Middle East and Africa Antithyroid Drug Market Size by Country in 2025
Figure 53. Middle East and Africa Antithyroid Drug Sales Market Share by Country (2021-2032)
Figure 54. Middle East and Africa Antithyroid Drug Revenue Market Share by Country (2021-2032)
Figure 55. Turkey Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Saudi Arabia Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. UAE Antithyroid Drug Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Global Antithyroid Drug Sales Market Share by Type (2021-2032)
Figure 59. Global Antithyroid Drug Revenue Market Share by Type (2021-2032)
Figure 60. Global Antithyroid Drug Price (US$/Unit) by Type (2021-2032)
Figure 61. Global Antithyroid Drug Sales Market Share by Application (2021-2032)
Figure 62. Global Antithyroid Drug Revenue Market Share by Application (2021-2032)
Figure 63. Global Antithyroid Drug Price (US$/Unit) by Application (2021-2032)
Figure 64. Antithyroid Drug Value Chain
Figure 65. Antithyroid Drug Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Antithyroid Drug Industry Opportunities and Challenges
提及公司
Avet Pharmaceuticals Inc.Par PharmaceuticalZhaohui PharmaceuticalHemony PharmaceuticalPfizer IncMerck KGaATeva PharmaceuticalsYanJing Pharm
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們